Hematocrit Values in the CAPD/CCPD Population

  • Anne S. Lindblad
  • Joel W. Novak
  • Karl D. Nolph
Part of the Developments in Nephrology book series (DINE, volume 23)

Abstract

A survey of the National CAPD Registry population was conducted to assess the distribution of hematocrit in a large group of CAPD/CCPD patients to characterize the anemia of the population, and identify factors which relate to variation in hematocrit. A random sample of 812 patients was selected from the Registry population. Information was provided on 608 patients. Population characteristics were similar to the Registry population as a whole. Mean hematocrit was 29.4% and median hematocrit was 29%. Recent peritonitis, folate therapy, androgen therapy, and iron therapy had no obvious influences on hematocrit distributions. Significantly higher hematocrits were seen in males, whites, and patients with polycystic kidney disease. Significantly lower hematocrits were seen in surgically anephric patients and in patients who had received transfusions 60 days before the survey. Eighty-nine percent of patients had not received a transfusion 60 days prior to the survey. Some patients, especially those with hematocrits below the median, might benefit from recombinant erythropoietin therapy.

Keywords

Polycystic Kidney Disease Continuous Ambulatory Peritoneal Dialysis Folate Supplement Hematocrit Level Iron Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fisher JW. Mechanism of the anemia of chronic renal failure. Nephron 1980; 25(3): 106–111.PubMedCrossRefGoogle Scholar
  2. 2.
    Editorial. The anemia of chronic renal failure. Lancet 1983; 1:965–966.Google Scholar
  3. 3.
    De Paepe MBJ, Schelstraete KHG, Ringoir SM, Lameire NH. Influence on continuous ambulatory peritoneal dialysis on the anemia of end stage renal disease. Kidney Int 1983; 23;744–748.PubMedCrossRefGoogle Scholar
  4. 4.
    Saltissi D, Coles GA, Napier AF, Bentley P. The hematological response to continuous ambulatory peritoneal dialysis. Clin Neph 1984 Jul; 22(1):21–27.Google Scholar
  5. 5.
    Mehta BR, Mogridge C, Bell JD. Changes in red cell mass, plasma volume and hematocrit in patients of CAPD. Trans Am Soc Artif Organs 1983 Apr; 29:50–52.Google Scholar
  6. 6.
    Summerfield GP, Gyde OHB, Forbves AMW, Goldsmith HJ, Bellingham AJ. Haemoglobin concentration and serum erythropoietin in renal dialysis and transplant patients. Scand J Haematol 1983; 30:389–400.PubMedCrossRefGoogle Scholar
  7. 7.
    Lampen S, Carozzi S, Icardi A. In vitro and in vivo studies of erythropoiesis during continuous ambulatory peritoneal dialysis. Peritoneal Dial Bull 1983 Apr–Jun; 3(2): 94–96.Google Scholar
  8. 8.
    Zappocosta AR, Caro J, Erslev A. Normalization of haemotocrit in patients with end stage renal disease on continuous ambulatory peritoneal dialysis. Am J Med 1982; 72:53–57.CrossRefGoogle Scholar
  9. 9.
    McGonigle RJS, Wallin JD, Shadduck RK, Fisher JW. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int 1984 Feb; 25(2):437–444.PubMedCrossRefGoogle Scholar
  10. 10.
    Kurtz SB, Wong VH, Anderson CF, Vogel JP, McCarthy JT, Mitchell JC, Kumar R, Johnson WJ. Continuous ambulatory peritoneal dialysis. Three years’ experience at the Mayo Clinic. Mayo Clin Proc 1983; 58:633–639.PubMedGoogle Scholar
  11. 11.
    Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythro-poietin: results of a phase I–II clinical trial. Am Soc Neph 1986 Dec 7–10; 19:41A. abstract.Google Scholar
  12. 12.
    Blumberg A, Hanek A, Saunder G. Vitamin nutrition in patients on CAPD. Clin Nephrol 1983; 20:244–250.PubMedGoogle Scholar
  13. 13.
    Donati RM, Lange RD, Gallagher NI. Nephrogenic erythrocytosis. Arch Intern Med 1963; 112:960.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • Anne S. Lindblad
    • 1
  • Joel W. Novak
    • 1
  • Karl D. Nolph
    • 2
  1. 1.Data Coordinating CenterThe EMMES CorporationPotomacUSA
  2. 2.University of MissouriColumbiaUSA

Personalised recommendations